Resultados de procura - Smita S. Chandran

  • Mostrando 1 - 13 Resultados de 13
Limitar resultados
  1. 1
    T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance

    T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance por Smita S. Chandran, Christopher A. Klebanoff

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome

    T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome por Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, Sergio A. Quezada, Antoni Ribas

    Publicado 2023
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis

    CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis por Anita L. Tang, John R. Teijaro, Modesta N. Njau, Smita S. Chandran, Agnes M. Azimzadeh, Steven G. Nadler, David M. Rothstein, Donna L. Färber

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans por Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity

    Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity por Jiaqi Ma, Cory M. Ayres, Chad A. Brambley, Smita S. Chandran, Tatiana J. Rosales, W. W. J. Gihan Perera, Bassant Eldaly, W. A. Murray, Steven A. Corcelli, Evgenii L. Kovrigin, Christopher A. Klebanoff, Brian M. Baker

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    The Stoichiometric Production of IL-2 and IFN-γ mRNA Defines Memory T Cells That Can Self-Renew After Adoptive Transfer in Humans

    The Stoichiometric Production of IL-2 and IFN-γ mRNA Defines Memory T Cells That Can Self-Renew After Adoptive Transfer in Humans por Anran Wang, Smita S. Chandran, Syed Ammer Shah, Yu Wen Chiu, Biman C. Paria, Tamara Aghamolla, Melissa M. Alvarez‐Downing, Chyi‐Chia Richard Lee, Sanmeet Singh, Thomas Li, Mark E. Dudley, Nicholas P. Restifo, Steven A. Rosenberg, Udai S. Kammula

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

    Identification of an Immunogenic Subset of Metastatic Uveal Melanoma por Luke D. Rothermel, Arvind Sabesan, Daniel J. Stephens, Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Robert Somerville, John R. Wunderlich, Chyi‐Chia Richard Lee, Liqiang Xi, Trinh H. Pham, Mark Raffeld, Parthav Jailwala, Manjula Kasoji, Udai S. Kammula

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy

    Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy por Christopher A. Klebanoff, Joseph G. Crompton, Anthony Leonardi, Tori N. Yamamoto, Smita S. Chandran, Robert Eil, Madhusudhanan Sukumar, Suman K. Vodnala, Jinhui Hu, Yun Ji, David Clever, Mary A. Black, Devikala Gurusamy, Michael J. Kruhlak, Ping Jin, David F. Stroncek, Luca Gattinoni, Steven A. Feldman, Nicholas P. Restifo

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study

    Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study por Smita S. Chandran, Robert Somerville, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Stephanie L. Goff, John R. Wunderlich, David N. Danforth, Daniel Zlott, Biman C. Paria, Arvind Sabesan, Abhishek K. Srivastava, Liqiang Xi, Trinh H. Pham, Mark Raffeld, Donald E. White, Mary Ann Toomey, Steven A. Rosenberg, Udai S. Kammula

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA por Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma

    Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma por Joal D. Beane, Gary Lee, Zhili Zheng, Matthew Mendel, Daniel Abate‐Daga, Mini Bharathan, Mary A. Black, Nimisha Gandhi, Zhiya Yu, Smita S. Chandran, Martin Giedlin, Dale Ando, Jeffrey C. Miller, David E. Paschon, Dmitry Guschin, Edward J. Rebar, Andreas Reik, Michael C. Holmes, Philip D. Gregory, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan, Steven A. Feldman

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    TOX is a critical regulator of tumour-specific T cell differentiation

    TOX is a critical regulator of tumour-specific T cell differentiation por Andrew Scott, Friederike Dündar, Paul Zumbo, Smita S. Chandran, Christopher A. Klebanoff, Mojdeh Shakiba, Prerak Trivedi, Laura Menocal, Heather Appleby, Steven Camara, Dmitriy Zamarin, Tyler Walther, Alexandra Snyder, Matthew R. Femia, Elizabeth Comen, Hannah Y. Wen, Matthew D. Hellmann, Niroshana Anandasabapathy, Yong Liu, Nasser K. Altorki, Peter Lauer, Olivier Levy, Michael S. Glickman, Jonathan Kaye, Doron Betel, Mary Philip, Andrea Schietinger

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias

    Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias por Won Jun Kim, Edie I. Crosse, Emma De Neef, Iñaki Etxeberría, Erich Sabio, Eric Wang, Jan Philipp Bewersdorf, Kuan‐Ting Lin, Sydney X. Lu, Andrea E. Belleville, Nina Fox, Cynthia Castro, Pu Zhang, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Beatrice Zhang, Jeffrey D. Winick, Alexander M. Lewis, Robert F. Stanley, Susan DeWolf, Brigita Meškauskaitė Urben, Meril Takizawa, Tobias Krause, Henrik Molina, Ronan Chaligné, Priya Koppikar, Jeffrey J. Molldrem, Mathieu Gigoux, Taha Merghoub, Anthony F. Daniyan, Smita S. Chandran, Benjamin D. Greenbaum, Christopher A. Klebanoff, Robert K. Bradley, Omar Abdel‐Wahab

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: